Axonal protective effects of the myelin-associated glycoprotein

Journal of Neuroscience

Volumn 29, Issue 3, 2009, Pages 630-637

  Nguyen, Thien ^a   Mehta, Niraj R ^a   Conant, Katherine ^a   Kim, Kee Jun ^c   Jones, Melina ^a   Calabresi, Peter A ^a   Melli, Giorgia ^a   Hoke, Ahmet ^a   Schnaar, Ronald L ^a   Ming, Guo Li ^a,b   Song, Hongjun ^a,b   Keswani, Sanjay C ^a   Griffin, John W ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Axon glia interaction; Axonal protection; MAG; Myelin; Myelin associated glycoprotein; Schwann cells

Indexed keywords

ACRYLAMIDE; MYELIN ASSOCIATED GLYCOPROTEIN; NEUROFILAMENT PROTEIN; NOGO 66 RECEPTOR; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CHO CELL; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOUSE; NERVE FIBER DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACRYLAMIDE; ACTION POTENTIALS; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTAGENESIS, SITE-DIRECTED; MYELIN PROTEINS; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE DEGENERATION; NERVE FIBERS, MYELINATED; NEURAL CONDUCTION; NEUROFILAMENT PROTEINS; NEUROPROTECTIVE AGENTS; PHOSPHOINOSITIDE PHOSPHOLIPASE C; RATS; RECEPTORS, CELL SURFACE; SPINAL CORD INJURIES; TIME FACTORS; TUBULIN; TUBULIN MODULATORS; VINCRISTINE;

EID: 58849088579     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5204-08.2009     Document Type: Article

References (39)

1. Baas PW, Black MM (1990) Individual microtubules in the axon consist of domains that differ in both composition and stability. J Cell Biol 111:495-509.
2. Berciano J, García A, Calleja J, Combarros O (2000) Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication. Neuromuscul Disord 10:419-424.
3. Bjartmar C, Wujek JR, Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 206:165-171.
4. Campenot RB (1982) Development of sympathetic neurons in compartmentalized cultures. II. Local control of neurite survival by nerve growth factor. Dev Biol 93:13-21.
5. Campenot RB (1992) Compartmented culture analysis of nerve growth. In: Cell-cell interactions: a practical approach (Stevenson BR, Gallin WJ, Hall DL, eds), pp 275-298. New York: Oxford UP.
6. Cao Z, Qiu J, Domeniconi M, Hou J, Bryson JB, Mellado W, Filbin MT (2007) The inhibition site on myelin-associated glycoprotein is within Ig-domain 5 and is distinct from the sialic acid binding site. J Neurosci 27:9146-9154.
7. Ciccarelli O, Werring DJ, Barker GJ, Griffin CM, Wheeler-Kingshott CA, Miller DH, Thompson AJ (2003) A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging - evidence of Wallerian degeneration. J Neurol 250:287-292.
8. Coleman MP, Perry VH (2002) Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci 25:532-537.
9. Dashiell SM, Tanner SL, Pant HC, Quarles RH (2002) Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J Neurochem 81:1263-1272.
10. DeBellard ME, Tang S, Mukhopadhyay G, Shen YJ, Filbin MT (1996) Myelin-associated glycoprotein inhibits axonal regeneration from a variety of neurons via interaction with a sialoglycoprotein. Mol Cell Neurosci 7:89-101.
11. de Waegh SM, Lee VM, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463.
12. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M (2002) Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35:283-290.
13. Dyck PJ (1975) Inherited neuronal degeneration and atrophy affecting peripheral motor, sensory, and autonomic neurons. Philadelphia: Saunders.
14. Ebenezer GJ, McArthur JC, Thomas D, Murinson B, Hauer P, Polydefkis M, Griffin JW (2007) Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain 130:2703-2714.
15. Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341-346.
16. Fournier AE, Takizawa BT, Strittmatter SM (2003) Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23:1416-1423.
17. Garcia ML, Lobsiger CS, Shah SB, Deerinck TJ, Crum J, Young D, Ward CM, Crawford TO, Gotow T, Uchiyama Y, Ellisman MH, Calcutt NA, Cleveland DW (2003) NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J Cell Biol 163:1011-1020.
18. Griffin JW, Thompson WJ (2008) Biology and pathology of nonmyelinating Schwann cells. Glia 56:1518-1531.
19. Hsieh ST, Kidd GJ, Crawford TO, Xu Z, Lin WM, Trapp BD, Cleveland DW, Griffin JW (1994) Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci 14:6392-6401.
20. Hsieh ST, Choi S, Lin WM, Chang YC, McArthur JC, Griffin JW (1996) Epidermal denervation and its effects on keratinocytes and Langerhans cells. J Neurocytol 25:513-524.
21. Kelm S, Pelz A, Schauer R, Filbin MT, Tang S, de Bellard ME, Schnaar RL, Mahoney JA, Hartnell A, Bradfield P, Crocker PR (1994) Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol 4:965-972.
22. Kim JE, Liu BP, Park JH, Strittmatter SM (2004) Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44:439-451.
23. Ko MH, Chen WP, Hsieh ST (2000) Cutaneous nerve degeneration induced by acrylamide in mice. Neurosci Lett 293:195-198.
24. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME (2000) Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 123:1516-1527.
25. Liu BP, Fournier A, GrandPré T, Strittmatter SM (2002) Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297:1190-1193.
26. Mehta NR, Lopez PH, Vyas AA, Schnaar RL (2007) Gangliosides and Nogo receptors independently mediate myelin-associated glycoprotein inhibition of neurite outgrowth in different nerve cells. J Biol Chem 282:27875-27886.
27. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228.
28. Milward E, Kim KJ, Szklarczyk A, Nguyen T, Melli G, Nayak M, Deshpande D, Fitzsimmons C, Hoke A, Kerr D, Griffin JW, Calabresi PA, Conant K (2008) Cleavage of myelin associated glycoprotein by matrix metalloproteinases. J Neuroimmunol 193:140-148.
29. Ng WP, Cartel N, Li C, Roder J, Lozano A (1996) Myelin from MAG-deficient mice is a strong inhibitor of neurite outgrowth. Neuroreport 7:861-864.
30. Oh J, Henry RG, Genain C, Nelson SJ, Pelletier D (2004) Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging. J Neurol Neurosurg Psychiatry 75:1281-1286.
31. Pan B, Fromholt SE, Hess EJ, Crawford TO, Griffin JW, Sheikh KA, Schnaar RL (2005) Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single-and double-null mice. Exp Neurol 195:208-217.
32. Rao MV, Campbell J, Yuan A, Kumar A, Gotow T, Uchiyama Y, Nixon RA (2003) The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate. J Cell Biol 163:1021-1031.
33. Schaumburg HH, Wiśniewski HM, Spencer PS (1974) Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J Neuropathol Exp Neurol 33:260-284.
34. Scherer S (1999) Axonal pathology in demyelinating diseases. Ann Neurol 45:6-7.
35. Tang S, Shen YJ, DeBellard ME, Mukhopadhyay G, Salzer JL, Crocker PR, Filbin MT (1997) Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J Cell Biol 138:1355-1366.
36. Trapp BD, Quarles RH (1982) Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 92:877-882.
37. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
38. Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953-1962.
39. Zheng YL, Li BS, Kanungo J, Kesavapany S, Amin N, Grant P, Pant HC (2007) Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell 18:404-413.